Works matching DE "RILPIVIRINE"


Results: 166
    1
    2
    3
    4
    5
    6
    7
    8
    9

    Factors associated with pre-treatment HIV RNA: application for the use of abacavir and rilpivirine as the first-line regimen for HIV-infected patients in resource-limited settings.

    Published in:
    AIDS Research & Therapy, 2017, v. 14, p. 1
    By:
    • Kiertiburanakul, Sasisopin;
    • Boettiger, David;
    • Oon Tek Ng;
    • Nguyen Van Kinh;
    • Merati, Tuti Parwati;
    • Avihingsanon, Anchalee;
    • Wing-Wai Wong;
    • Man Po Lee;
    • Chaiwarith, Romanee;
    • Kamarulzaman, Adeeba;
    • Kantipong, Pacharee;
    • Fujie Zhang;
    • Jun Yong Choi;
    • Kumarasamy, Nagalingeswaran;
    • Ditangco, Rossana;
    • Do Duy Cuong;
    • Oka, Shinichi;
    • Lim Heng Sim, Benedict;
    • Ratanasuwan, Winai;
    • Penh Sun Ly
    Publication type:
    Article
    10
    11
    12
    13
    14
    15
    16
    17
    18
    19

    HIV-1 subtype B-infected MSM may have driven the spread of transmitted resistant strains in France in 2007-12: impact on susceptibility to first-line strategies.

    Published in:
    Journal of Antimicrobial Chemotherapy (JAC), 2015, v. 70, n. 7, p. 2084, doi. 10.1093/jac/dkv049
    By:
    • Frange, Pierre;
    • Assoumou, Lambert;
    • Descamps, Diane;
    • Chéret, Antoine;
    • Goujard, Cécile;
    • Tran, Laurent;
    • Gousset, Marine;
    • Avettand-Fenoël, Veronique;
    • Bocket, Laurence;
    • Fafi-Kremer, Samira;
    • Guinard, Jerome;
    • Morand-Joubert, Laurence;
    • Nicot, Florence;
    • Plantier, Jean-Christophe;
    • Rogez, Sylvie;
    • Wirden, Marc;
    • Rouzioux, Christine;
    • Meyer, Laurence;
    • Chaix, Marie-Laure
    Publication type:
    Article
    20
    21
    22
    23
    24
    25
    26
    28
    29
    30
    31
    32
    33

    Hepatic safety of RPV/FTC/TDF single tablet regimen in HIV/HCV-coinfected patients. Preliminary results of the hEPAtic Study.

    Published in:
    Journal of the International AIDS Society, 2014, v. 17, p. n/a, doi. 10.7448/IAS.17.4.19631
    By:
    • Neukam, Karin;
    • Espinosa, Nuria;
    • Merino, Dolores;
    • Rivero-Juárez, Antonio;
    • Carrero, Ana;
    • José Ríos, María;
    • Ruiz-Morales, Josefa;
    • Gómez-Berrocal, Ana;
    • Téllez, Francisco;
    • Díaz-Menéndez, Marta;
    • Collado, Antonio;
    • Pérez-Camacho, Inés;
    • Delgado-Fernández, Marcial;
    • Vera-Méndez, Francisco;
    • Pineda, Juan A
    Publication type:
    Article
    34
    35

    Determinants of use of the fixed dose combination emtricitabine/rilpivirine/tenofovir (Eviplera) in HIV-infected persons receiving care in Italy.

    Published in:
    Journal of the International AIDS Society, 2014, v. 17, p. n/a, doi. 10.7448/IAS.17.4.19775
    By:
    • Cozzi-Lepri, Alessandro;
    • Lo Caputo, Sergio;
    • Maggiolo, Franco;
    • Antinori, Andrea;
    • Ammassari, Adriana;
    • Marchetti, Giulia;
    • Mastroianni, Claudio;
    • Gori, Andrea;
    • Di Perri, Giovanni;
    • Angarano, Gioacchino;
    • Carbone, Alessia;
    • d'Arminio Monforte, Antonella
    Publication type:
    Article
    36
    37
    38
    39
    40
    41
    42

    Simplification to co-formulated rilpivirine/emtricitabine/tenofovir in virologically suppressed patients: Data from a multicenter cohort.

    Published in:
    Journal of the International AIDS Society, 2014, v. 17, p. n/a, doi. 10.7448/IAS.17.4.19812
    By:
    • Pinnetti, Carmela;
    • Di Giambenedetto, Simona;
    • Maggiolo, Franco;
    • Lorenzini, Patrizia;
    • Fabbiani, Massimiliano;
    • Tommasi, Chiara;
    • Latini, Alessandra;
    • Ammassari, Adriana;
    • Loiacono, Laura;
    • Sterrantino, Gaetana;
    • Bellagamba, Rita;
    • Boumis, Evangelo;
    • Antinori, Andrea;
    • Zaccarelli, Mauro
    Publication type:
    Article
    43
    44
    45

    Abacavir/Lamivudine plus Rilpivirine Is an Effective and Safe Strategy for HIV-1 Suppressed Patients: 48 Week Results of the SIMRIKI Retrospective Study.

    Published in:
    PLoS ONE, 2016, v. 11, n. 10, p. 1, doi. 10.1371/journal.pone.0164455
    By:
    • Troya, Jesús;
    • Ryan, Pablo;
    • Ribera, Esteban;
    • Podzamczer, Daniel;
    • Hontañón, Victor;
    • Terrón, Jose Alberto;
    • Boix, Vicente;
    • Moreno, Santiago;
    • Barrufet, Pilar;
    • Castaño, Manuel;
    • Carrero, Ana;
    • Galindo, María José;
    • Suárez-Lozano, Ignacio;
    • Knobel, Hernando;
    • Raffo, Miguel;
    • Solís, Javier;
    • Yllescas, María;
    • Esteban, Herminia;
    • González-García, Juan;
    • Berenguer, Juan
    Publication type:
    Article
    46
    47
    48
    49
    50